Symbols

NXL

Nexalin Technology·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Signals Analysis

Bullish signal 2

Bearish signal 0

Ample Liquidity

High Gross Profit Margin

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About NXL

Nexalin Technology, Inc.

A company that develops Nexalin medical device to treat depression, anxiety, insomnia, addiction, and early dementia

Industry

Healthcare Equipment and Supplies

Established Date

10/19/2010

Listing Date

09/16/2022

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.nexalin.com

Security Type

Common stock

Office address

1776 Yorktown, Suite 550, Houston, TX 77056

Business

Introduction

Nexalin Technology, Inc., was incorporated as a Nevada corporation on October 19, 2010. On December 1, 2021, the Company became a newly formed Delaware corporation. The company designs and develops innovative neurostimulation products that help combat the ongoing global mental health epidemic in unique and effective ways. The company has developed an easy-to-manage medical device — dubbed "Generation 1" or "Gen 1" — that uses bioelectronic medical technology to treat anxiety and insomnia without the need for medication or psychotherapy. The Company's original Gen-1 device, a cranial electrotherapy stimulation (CES) device that emits waveforms at 4 mAh during treatment, is currently classified as a Class II device by the U.S. Food and Drug Administration (" FDA ").

Company Financials

EPS

NXL has released its 2025 Q3 earnings. EPS was reported at -0.13, versus the expected -0.12, missing expectations. The chart below visualizes how NXL has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

NXL has released its 2025 Q3 earnings report, with revenue of 18.15K, reflecting a YoY change of -49.63%, and net profit of -2.28M, showing a YoY change of 7.02%. The Sankey diagram below clearly presents NXL's revenue sources and cost distribution.